Europe Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Allergy Type and Treatment

The Europe allergy treatment market is expected to reach US$ 10,424.97 million by 2028 from US$ 6,036.60 million in 2020, it is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to key driving factors such as increase in adoption of immunotherapy in allergy treatment and developments in food allergy treatments. However, the lack of awareness about allergy treatments restrains the market growth.

The allergies are hypersensitive responses from human immune system to the substance that are foreign to the body. While allergies can disturb the normal functioning of organs, severe allergies can be life threatening; for example, asthma leads to poor lung functioning. Although the most effective method of gaining protection against allergies is to avoid being exposed to the known allergens, medications such as steroids and antihistamines are available for treating them. According to a European survey in 2019, in Europe, the prevalence of allergic rhinitis ranges from 17 to 29%, whereas the prevalence of asthma varies from 1.3 to 11% among children and adults. Immunotherapy has shown positive and long-term benefits in allergic patients. In addition, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for both chronic and recurrent allergies. Also, developments in the pharmaceuticals industry have enabled companies to offer treatment for varied allergy reactions. Such developments in the food allergy treatment options and their effectiveness boost the growth of the Europe allergy treatment market.

The rapid growth of COVID-19 cases in Europe has had a major impact on the European economy. Amid COVID-19 outbreak pandemic, it is discovered that a significant number of people across the world are suffering from chronic respiratory diseases such as respiratory allergies, allergic rhinitis, and sinusitis. EAACI, in collaboration with ARIA, in Europe has provided recommendations on operational plans and practical procedures for ensuring optimal standards in the daily clinical care of patients affected by allergic diseases. Therefore, the growing demand for allergy treatments in Europe boosts the growth of the allergy treatment market in the region.

The Europe allergy treatment market, based on allergy type, is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the market for the food allergies segment is expected to grow at the fastest rate during the coming years.

The Europe allergy treatment market, based on treatment, is bifurcated into anti-allergy drugs and immunotherapy. In 2020, the anti-allergy drugs segment held a larger market share. However, the market for the immunotherapy segment is expected to grow at the fastest rate during the coming years.

A few of the primary and secondary sources referred to while preparing the report on the Europe allergy treatment market are Allergy UK Organization (AUKO), European Academy of Allergy and Clinical Immunology (EAACI), and Spanish Society of Pneumology and Thoracic Surgery (SEPAR).

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe allergy treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe allergy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.